Abbott Completes Acquisition of Exact Sciences, Establishing Abbott as a Leader in Fast-Growing Cancer Screening and Diagnostics Segments

Abbott (NYSE: ABT) today announced it has completed the acquisition of Exact Sciences, establishing Abbott as a leader in fast-growing cancer screening and diagnostics segments and enabling the company to serve millions of additional people.

“Abbott’s global scale, track record of operational and commercial excellence and work with healthcare systems around the world will expand access to important tools for early cancer detection and personalized treatments,” said Robert B. Ford, chairman and chief executive officer, Abbott. “With the legacy and deep expertise of the Exact Sciences team, we’re ready to transform cancer care.”

Read more at Yahoo!Finance